08:59 AM EDT, 07/01/2025 (MT Newswires) -- Health care stocks were leaning lower premarket Tuesday with the iShares Biotechnology ETF (IBB) marginally declining and the Health Care Select Sector SPDR Fund (XLV) down 0.2% recently.

ATAI Life Sciences ( ATAI ) shares were up 28% after the company and Beckley Psytech said their phase 2b trial of BPL-003, which is intended for patients with treatment-resistant depression, met primary and all secondary endpoints.